First Booster of SARS-COV-2 mRNA Vaccine Is Not Associated With Alloimmunization and Subclinical Injury of Kidney Allograft
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu dopisy, práce podpořená grantem
PubMed
36314999
DOI
10.1097/tp.0000000000004421
PII: 00007890-202302000-00040
Knihovny.cz E-zdroje
- MeSH
- alografty MeSH
- autoimunitní hemolytická anemie * MeSH
- COVID-19 * prevence a kontrola MeSH
- ledviny MeSH
- lidé MeSH
- mRNA vakcíny MeSH
- protilátky virové MeSH
- SARS-CoV-2 MeSH
- vakcíny proti COVID-19 * aplikace a dávkování MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
- práce podpořená grantem MeSH
- Názvy látek
- protilátky virové MeSH
- vakcíny proti COVID-19 * MeSH
Department of Nephrology Institute for Clinical and Experimental Medicine Prague Czech Republic
Immunogenetics Department Institute for Clinical and Experimental Medicine Prague Czech Republic
Transplant Laboratory Institute for Clinical and Experimental Medicine Prague Czech Republic
Zobrazit více v PubMed
Levin EG, Lustig Y, Cohen C, et al. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N Engl J Med. 2021;385:e84.
American Society of Transplantation. COVID-19 vaccine FAQ sheet (updated 5/4/2022). 2022. Available at https://www.myast.org/sites/default/files/2022.05.04%20AST%20Vaccine%20FAQ-CLEAN.pdf . Accessed June 16, 2022.
Goldman M. The safety of anti-SARS-CoV-2 vaccines: vigilance is still required. J Clin Med. 2022;11:1248.
Medina-Pestana J, Almeida Viana L, Nakamura MR, et al. Immunogenicity after a heterologous BNT262b2 versus homologous booster in kidney transplant recipients receiving 2 doses of coronavac vaccine: a prospective cohort study. Transplantation. [Epub ahead of print. August 5, 2022]. doi:10.1097/TP.0000000000004260 DOI
Locke JE, Zachary AA, Warren DS, et al. Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody. Am J Transplant. 2009;9:2136–2139.
Halloran PF, Reeve J, Madill-Thomsen KS, et al. The Trifecta study: comparing plasma levels of donor-derived cell-free DNA with the molecular phenotype of kidney transplant biopsies. J Am Soc Nephrol. 2022;33:387–400.
Oellerich M, Sherwood K, Keown P, et al. Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury. Nat Rev Nephrol. 2021;17:591–603.
Park S, Guo K, Heilman RL, et al. Combining blood gene expression and cellfree DNA to diagnose subclinical rejection in kidney transplant recipients. Clin J Am Soc Nephrol CJASN. 2021;16:1539–1551.
Paul RS, Almokayad I, Collins A, et al. Donor-derived cell-free DNA: advancing a novel assay to new heights in renal transplantation. Transplant Direct. 2021;7:e664.
Süsal C, Wettstein D, Döhler B, et al. Association of kidney graft loss with de novo produced donor-specific and non-donor-specific HLA antibodies detected by single antigen testing. Transplantation. 2015;99:1976–1980.
Eurotransplant. Virtual PRA calculator. 2022. Available at https://www.etrl.org/vPRA.aspx .
